Chief Scientific Officer, Nano-Bioanalytik-Zentrum Münster
Dr. Klaus-Michael Weltring is a molecular biologist by training with a PhD and a Habilitation degree from the University of Münster. Since 2001 he is the managing director of bioanalytik-muenster responsible for the development of the Münster region into a leading nanobioanalytic location at the European level. He has set-up a local network of researchers from different disciplines and SMEs and organizes the marketing of the region at international events and fairs. Between 2003 and 2008 he was the deputy-coordinator of the Nano2Life Network of Excellence and leader of the “ELSA” Board in this network. He co-managed the Nanomedicine Round Table and the EuroNanoBio projects and participated in the NANOMED2020 project (FP7 CSA projects). Since 2009 he is a member of the Executive Board of the ETP Nanomedicine leading the ELSA Advisory Group of this platform. Currently he is the Chief Scientific Officer of the Nano-Bioanalytik-Zentrum Münster (NBZ) and manages the Nano-Characterization-Lab Muenster (www.NCL-Muenster.de) of 11 local companies, which develop new and certified methods for characterization of Nanomaterials in consumer products and biological systems.